Over the past few months, there has been a significant amount of discussion surrounding the General Dental Council’s updated Scope of Practice guidance and what it means for dentists providing facial aesthetics.
Much of the conversation online has been emotionally charged, speculative, or commercially motivated. Some have framed the change as a “ban” on dentists carrying out aesthetic medicine. Others have used it to promote courses, memberships, accreditation schemes, or fear-based messaging around compliance. The reality is considerably more nuanced.
Importantly, this is also not “breaking news”. The revised guidance was published by the GDC in September 2025 and became effective from 1 November 2025. We are now many months beyond implementation, and despite widespread discussion, there has been very little objective analysis of what actually changed, what did not change, and what the practical implications are for dentists providing non-surgical aesthetic procedures.
This article aims to focus on facts rather than opinion.
What actually changed?
In the previous 2013 GDC Scope of Practice guidance, dentists were listed as being able to develop additional skills including: “Providing non surgical cosmetic injectables.”
In the revised 2025 guidance, this wording has been removed. That is the change that has generated the majority of concern within dentistry and aesthetics. However, the GDC itself also stated that the revised guidance: “has not changed the scope of practice for any of the seven dental professional titles.”
Source: General Dental Council, Revised Scope of Practice Guidance
This distinction is critical. The updated guidance does not state that dentists are prohibited from carrying out facial aesthetics. It does not state that injectables are illegal for dentists. It does not remove a dentist’s ability to undertake additional training or practise in adjacent healthcare fields.
What it does do is remove the explicit inclusion of “non-surgical cosmetic injectables” from the illustrative examples within the Scope guidance. That may sound subtle, but professionally and regulatorily, it matters.
So what is different in practical terms?
Previously, many clinicians took reassurance from the fact that facial aesthetics appeared directly within GDC Scope guidance. It gave the impression that aesthetic injectables sat comfortably within dentistry itself. The revised guidance creates more separation between dentistry and aesthetic medicine.
In other words, the GDC is no longer positively framing facial aesthetics as an example of a dental skill extension. That does not automatically make the practice unsafe, inappropriate, or prohibited. But it does mean clinicians can no longer rely on the simplistic argument: “It’s in the GDC Scope of Practice, therefore it’s covered.”
Instead, dentists providing aesthetic medicine now need to demonstrate something more robust:
- Appropriate training
- Ongoing competence
- Suitable indemnity
- Appropriate prescribing practice
- Safe patient selection
- Valid consent
- Strong documentation
- Complication management pathways
- Appropriate governance and premises standards
Ultimately, the emphasis shifts further towards individual professional accountability.
Was the GDC ever regulating injectables anyway?
This is one of the most misunderstood parts of the conversation. The GDC regulates dental professionals. It does not directly regulate dermal fillers or botulinum toxin procedures themselves in the same way that, for example, the Care Quality Commission regulates certain healthcare services.
Even before the 2025 update, aesthetic medicine sat within a relatively fragmented regulatory environment. Botulinum toxin has always been regulated separately as a prescription only medicine under medicines legislation.
Advertising restrictions are governed separately by the Advertising Standards Authority.
Consumer protection legislation applies separately. Premises regulation may involve the CQC depending on the services provided. Product safety involves the MHRA.
This means that even when facial aesthetics appeared within the old Scope guidance, dentists were never operating under a single unified “GDC aesthetics framework”. The update has simply made this reality more visible.
What is the practical impact for dentists?
For well trained, ethical, properly governed clinicians, the practical day to day impact is likely to be relatively limited. Dentists can still legally provide aesthetic injectables provided they practise lawfully and competently. However, the clinicians most exposed are those who:
- Have minimal training
- Rely heavily on remote prescribing models
- Lack robust consent processes
- Have weak complication protocols
- Have unclear indemnity arrangements
- Poorly document cases
- Market aggressively or misleadingly
- Treat aesthetics as an informal “side add on” rather than a healthcare service requiring governance
The direction of travel across healthcare regulation has been obvious for several years now. More scrutiny. More accountability. More governance. More emphasis on evidence of competence. This update aligns with that broader trajectory.
How can dentists ensure best practice and compliance?
This is where the conversation becomes genuinely important. Rather than reacting emotionally to headlines, clinicians should use this moment to critically evaluate the quality of their systems, governance, and clinical standards.
Questions worth asking yourself include:
Training and competence
- Have I undertaken comprehensive training beyond entry level courses? And how is this documented and recorded?
- Do I have evidence of ongoing CPD?
- Can I justify the procedures I provide based on competence, not confidence?
- Am I appropriately trained in anatomy and complication management?
Prescribing
- Is my botulinum toxin prescribing model lawful and defensible?
- Are consultations genuinely patient specific?
- Is prescribing occurring appropriately and ethically?
- Am I documenting appropriately?
Consent
- Is my consent process procedure specific and complication specific?
- Do patients understand vascular occlusion risk, delayed inflammatory reactions, migration, asymmetry, and off label use where relevant?
- Is consent documented comprehensively?
Complications
- Do I have a written vascular occlusion protocol?
- Do I stock emergency medications appropriately?
- Do I know where I would refer a patient in an emergency?
- Could I manage a complication safely at 6pm on a Friday evening?
Indemnity
- Is my insurer fully aware of exactly what procedures I perform?
- Am I covered for complications arising from aesthetic practice?
Documentation
- Are photographs standardised?
- Are batch numbers recorded?
- Are consultations, diagnosis and treatment plans documented appropriately?
- Would my records withstand scrutiny in court or before a regulator?
Governance
- Are my premises appropriate?
- Is infection control appropriate?
- Are policies written and reviewed?
- Are adverse events documented and audited?
This is where the profession should focus its energy. Not panic. Not sensationalism. Not fear based marketing. Governance.
Do dentists need additional accreditation or regulation?
This is where significant confusion exists. There are now multiple organisations, registers, accreditation schemes and “compliance” bodies operating within aesthetics. Some provide valuable structure and standards. Others are largely commercial. It is important to distinguish between the two.
Which organisations are relevant?
The JCCP
The Joint Council for Cosmetic Practitioners was established following recommendations from the Keogh Review into cosmetic interventions. Its purpose is to improve patient safety standards within aesthetics through voluntary registration and educational frameworks. Importantly:
- JCCP registration is currently voluntary
- It is not a statutory regulator
- It does not replace the GDC
- Lack of JCCP registration does not make aesthetic practice unlawful
That said, some clinicians may choose to utilise JCCP frameworks as part of strengthening governance and demonstrating commitment to recognised standards. That is a reasonable professional decision. What becomes problematic is when marketing implies: “You cannot legally practise without this.” That is not currently factually correct.
What scare tactics should clinicians watch for?
There has unfortunately been an increase in fear based messaging around the GDC update. Examples include:
- “Dentists can no longer legally inject.”
- “You must join X organisation immediately.”
- “You are no longer insured.”
- “You are now practising illegally.”
- “The GDC has banned Botox.”
These statements are generally inaccurate or materially oversimplified. The reality is more measured. The regulatory environment is tightening. Expectations around governance are increasing. Poor practice is becoming harder to defend. But competent, well governed dentists providing aesthetic medicine are not suddenly prohibited from practising.
What does the wider regulatory landscape look like?
The Government has already moved towards increased regulation of non-surgical cosmetic procedures. The Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 made it illegal in England to administer cosmetic botulinum toxin or fillers to under 18s except in limited medical circumstances.
There are also ongoing plans around practitioner and premises licensing for aesthetic procedures. This tells us something important. The long-term trajectory is likely towards:
- Greater standardisation
- Higher training expectations
- Increased governance
- Safer prescribing frameworks
- Better complication reporting
- More formal oversight of practitioners and premises
The profession should prepare accordingly.
So what is the bottom line?
The GDC Scope of Practice update did not ban dentists from providing facial aesthetics. It did not suddenly make injectables illegal. It did not create a brand new problem overnight.
What it did do was remove the explicit inclusion of “non-surgical cosmetic injectables” from the GDC’s Scope guidance, placing greater emphasis on individual professional accountability and broader healthcare governance.
For clinicians practising responsibly, with strong systems and genuine competence, this should not create panic. For clinicians relying on weak training, poor governance, vague indemnity, or outdated prescribing models, this update should absolutely act as a wakeup call. The safest and strongest position moving forward is not defensiveness.
It is professionalism.
Strong training. Strong governance. Strong ethics. Strong documentation. Strong patient care. Because ultimately, regardless of whether aesthetics appears in a Scope of Practice document or not, patient safety remains the standard against which all clinicians will be judged.
References
- General Dental Council, Scope of Practice Guidance 2025
- General Dental Council, Scope of Practice Guidance 2013
- MHRA guidance on botulinum toxin and prescription medicines
- UK Government consultation response on licensing non surgical cosmetic procedures
- Advertising Standards Authority guidance on Botox advertising
- Joint Council for Cosmetic Practitioners
